The pharmaceutical industry has a substantial impact on the environment, especially when the materials used to make them and the chemicals that comprise make their way directly into the environment.
The Drugs Controller General of India (DCGI) granted permission on Wednesday for conducting the phase-3 clinical trial of COVID-19 vaccine Covovax as a booster dose in adults, official sources said. The Subject Expert Committee (SEC) on COVID-19 .
Novavax Inc said on Tuesday its COVID-19 vaccine has got emergency-use authorization from the Drugs Controller General of India for children aged 12 to 17 years.
Health tech startup FutureCure Health has secured around USD 4 million (about Rs 30.4 crore) in series A funding round from RVCF India Growth Fund, Unicorn India Ventures, Kotak Investment Advisor Limited, and other investors,
Chennai-based TTK Healthcare is set to sell its human pharma division to Mumbai-based Bharat Serums and Vaccines (BSV) for Rs 805 crore. The board of TTK Healthcare accepted the sale on Monday as a going concern on a slump sale basis.
Sun Pharmaceutical Industries on Monday said it has entered into a share purchase agreement with Japan's Daiichi Sankyo Company to gain the latter's 11.28% stake in Zenotech Laboratories.
The Medicines Patent Pool (MPP) recently declared that it has signed agreements with 35 companies, including Cadila Pharma, Torrent Pharma, Aurobindo Pharma, MSN Group, SMS Pharma, Granules India, to manufacture the generic version of Pfizer’s oral
Bristol Myers Squibb Co said on Friday that U.S. regulators approved the first drug in a new class of cancer immunotherapies as an initial treatment for advanced melanoma, the deadliest form of skin cancer.
Quess Corp chairman Ajit Isaac and his wife Sarah Isaac have committed Rs 105 crore to set up the Isaac Centre for Public Health at the Indian Institute of Science (IISc) campus in Bengaluru by 2024. The objective is to create best-in-class post-grad
The increasing need for pharmaceuticals has led to the growing willingness to outsource drug development to Contract Drug Manufacturing Organizations (CDMOs).